TJBH — Tengjun Biotechnology Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 73.74% | ||
| Return on Equity | 84.97% | ||
| Operating Margin | 10.92% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | 150.14 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Tengjun Biotechnology Corp, formerly China Herb Group Holdings Corp, is a holding company mainly engaged in the Chinese tea and water purifier businesses. The Company operates its businesses through two segments. The Dandelion Teas segment produces two types of teas, green dandelion tea and black dandelion tea. The Water Purifier segment is engaged in manufacturing and selling consumer water purifiers. The Company conducts its businesses in the domestic market.
Directors
- Last Annual
- December 31st, 2022
- Last Interim
- June 30th, 2023
- Incorporated
- June 28th, 2010
- Public Since
- September 16th, 2010
- No. of Shareholders
- 167
- No. of Employees
- 27
- Sector
- Household Goods
- Industry
- Consumer Cyclicals
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 100,711,196
- Address
- Food Industry Economic And Technology, WUXI, 214028
- Web
- Phone
- +1 7032321726
- Auditors
- KCCW Accounting Corp
Upcoming Events for TJBH
Similar to TJBH
Azzurro Solutions
Pink Sheets on Nasdaq
Bruush Oral Care
Pink Sheets on Nasdaq
Deer Consumer Products
Pink Sheets on Nasdaq
Dixie
Pink Sheets on Nasdaq
IDP Holdings (USA)
Pink Sheets on Nasdaq
FAQ
As of Today at 22:37 UTC, shares in Tengjun Biotechnology are trading at $2.00. This share price information is delayed by 15 minutes.
Shares in Tengjun Biotechnology last closed at $2.00 and the price had moved by -50% over the past 365 days. In terms of relative price strength the Tengjun Biotechnology share price has underperformed the S&P500 Index by -59.72% over the past year.
There is no consensus recommendation for this security.
Find out moreTengjun Biotechnology does not currently pay a dividend.
Tengjun Biotechnology does not currently pay a dividend.
Tengjun Biotechnology does not currently pay a dividend.
To buy shares in Tengjun Biotechnology you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $2.00, shares in Tengjun Biotechnology had a market capitalisation of .
Here are the trading details for Tengjun Biotechnology:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: TJBH
Based on an overall assessment of its quality, value and momentum Tengjun Biotechnology is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Tengjun Biotechnology. Over the past six months, its share price has underperformed the S&P500 Index by -94.99%.
As of the last closing price of $2.00, shares in Tengjun Biotechnology were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Tengjun Biotechnology PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $2.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Tengjun Biotechnology's management team is headed by:
- Xianchang Ma - CEO
- Huaping Lu - DRC
- Suzhen Zhang - DRC